“…Lastly, we want to briefly bring attention to some articles that are important to HDX MS in their own right, which may guide and drive some of the future development of the field outside of the broad areas of LC, MS, or data processing. These articles include use of HDX MS in biopharma to monitor changes due to chemical modification (e.g., methionine oxidation), decoupled automation wherein sample preparation is a separate automation process from automated LC–MS, deamidation and protein stability, optimizing various points along the experimental workflow, including and exploiting PTMs during analysis, internal standards that report on the exchange conditions and back-exchange along the analysis pathway in order to correct for experimental condition fluctuations, capillary electrophoresis for separating coexisting protein states that are all deuterated together, and corrections to account for buffer additives that can alter the intrinsic rate of exchange …”